SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices approach all-time highs, fueled by speculation around potential Fed rate cuts and renewed interest in precious metals as a hedge against economic uncertainty. Community members are discussing technical breakouts, potential for a silver squeeze, and historical inflation-adjusted valuations, while some express concerns about market manipulation and potential pullbacks. The broader context involves increased industrial demand for silver and its role as a safe-haven asset amid global economic concerns.

Abaxx Technologies, Inc. development-stage financial technology company, which develops software tools that enable commodity traders and finance professionals to communicate trade and transact faster and more securely. Its software technologies include deep learning and natural language processing (DL/NPL), self-sovereign digital identity (SSI), encrypted content-addressing distributed file systems, smart contracting languages and protocols, and decentralized datastore technology (DDS). The company was founded by Joshua Dale Crumb, Thomas McMahon and Andrew Fedak on January 25, 2018 and is headquartered in Toronto, Canada.

Abaxx Technologies Inc

Recent news and partnerships are driving interest in Abaxx, with community members pointing to its potential to disrupt commodity markets. Many are drawing comparisons to Nvidia and Palantir, highlighting the company's innovative approach and future growth potential. The discussion also revolves around the anticipation of upcoming milestones and the impact on the stock's valuation.

BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF

iShares Biotechnology ETF

IBB is trending as traders discuss AI's impact on biotech, potential M&A activity, and revenue multiples compared to peers. Community members are weighing in on potential upside, technical analysis, and individual stock performance within the biotech sector. Recent news about Centers for Medicare & Medicaid Services (CMS) price cuts may also be impacting the ETF.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is trending amid mixed community sentiment, with some expressing frustration over its price performance compared to Bitcoin and other altcoins.  Discussions also involve comparisons to Keeta, highlighting Cardano's methodical approach versus Keeta's focus on high-speed, compliant infrastructure; the potential launch of Midnight token, and speculation around an ADA ETF.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

QQQI is trending as investors discuss its high dividend yield and tax advantages, particularly Return of Capital (ROC), making it attractive for taxable accounts. Community members are weighing QQQI against alternatives like JEPQ, focusing on long-term income generation and NAV stability. Some are considering QQQI for retirement income, emphasizing its predictable monthly payouts amidst market volatility.

Global X Funds - Global X Funds Global X Robotics & Artificial Intelligence ETF

Global X Funds Global X Robotics & Artificial Intelligence ETF

$BOTZ is trending as investors weigh the potential of AI and robotics against concerns of a possible tech bubble and broader economic weakness. Discussions revolve around the ETF's key holdings, including NVDA, and its exposure to the US-China AI arms race, with community members analyzing its long-term growth prospects.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley ($MS) is trending amid discussions around bank regulations, potential M&A activity, and analysts weighing in on its financial outlook and strategic shifts. The community is focused on institutional ownership, potential earnings catalysts, and its position relative to competitors like Goldman Sachs ($GS). Recent news includes Morgan Stanley expanding crypto access and analysts adjusting price targets, driving both bullish and bearish sentiment.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs ($PL) is trending amid discussions about upcoming earnings and the company's growth potential within the space sector. Community members are analyzing technical indicators and potential government contracts, while also weighing bullish and bearish sentiment. Recent news includes partnerships and contract renewals which are adding to overall positive long-term sentiment.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as the community digests mixed earnings results, with streaming growth offset by declines in linear TV. Community discussion also centers on Disney's ongoing dispute with YouTube TV and potential impacts from upcoming movie releases like Zootopia 2. Despite some bearish sentiment, analysts are weighing in with price target adjustments, and some investors are seeing a buying opportunity.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is trending as the community discusses its long-term potential, interoperability and recent supply cap implementation.  Some investors view it as a solid project for cross-chain applications, while others are weighing its potential against emerging Layer 1 solutions focused on high-speed settlement and compliance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Janux Therapeutics (NASDAQ:JANX) Trading 10.2% Higher - What's Next?

Janux Therapeutics (NASDAQ:JANX) Trading Up 10.2% - What's Next...

Janux Therapeutics (NASDAQ:JANX) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $70.00 price target on shares of Janux Therapeutics in a report on Tuesday...

Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor...

Janux Therapeutics (NASDAQ:JANX) Now Covered by Wolfe Research

Wolfe Research initiated coverage on shares of Janux Therapeutics in a report on Tuesday. They set a "peer perform" rating for the company...

Andrew Hollman Meyer Sells 3,333 Shares of Janux Therapeutics (NASDAQ:JANX) Stock

Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) insider Andrew Hollman Meyer sold 3,333 shares of the company's stock in a transaction dated Friday, November 14th. The stock was sold at an...

Janux Therapeutics (NASDAQ:JANX) Stock Price Up 8.5% - Here's What Happened

Janux Therapeutics (NASDAQ:JANX) Trading Up 8.5% - Here's What Happened...

Janux Therapeutics (NASDAQ:JANX) Insider Andrew Hollman Meyer Sells 3,333 Shares

Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) insider Andrew Hollman Meyer sold 3,333 shares of Janux Therapeutics stock in a transaction on Friday, November 14th. The stock was sold at an...

What is HC Wainwright's Estimate for JANX FY2025 Earnings?

Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings per share estimates for shares of Janux Therapeutics in a research...

Janux Therapeutics' (JANX) Outperform Rating Reaffirmed at Wedbush

Wedbush reaffirmed an "outperform" rating and set a $76.00 price target on shares of Janux Therapeutics in a research report on Friday...

Janux Therapeutics (NASDAQ:JANX) Trading Down 11.7% - Here's What Happened

Janux Therapeutics (NASDAQ:JANX) Stock Price Down 11.7% - Here's Why...

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Janux Therapeutics Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Current Price	$34.09
Prev Close	$34.69
Open	$34.67
Dividend Yield	0.00%
50-Day Moving Average	$26.85
Beta	1.49
Avg. Volume	1.14M
PE Ratio	-20.35

52-Week High	$71.71
52-Week Low	$21.73
Market Capitalization	$2.1B
EPS (Annual)	-$1.28
Price to Book	2.10
Revenue Per Employee	$130,716.05
Enterprise Value/EBITDA	N/A

JANX
Janux Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JANX News

JANXJanux Therapeutics Inc